137862-53-4 | Valsartan
Appearance white to tan powder
Purity 99.7% Min.
Application pharmaceutical intermediate
• The above information is for reference only.
• For further more information, please email us [email protected].
L-Valine;
N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-;
3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-butanoicaci;
(S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]amine;
(S)-2-(N-((2′-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoicaci;
Valsartan;
• The above information is for reference only.
• For further more information, please email us [email protected].